A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma
A Phase I/II Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Using the Intra-patient Escalation Dosing Regimen in Patients With Advanced Uveal Melanoma
Sponsor: Immunocore Ltd
A PHASE1/PHASE2 clinical study on Uveal Melanoma, this trial is completed. The trial is conducted by Immunocore Ltd and has accumulated 33 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
33 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE1/PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Apr 2023 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
Status: Active Not Recruiting → Completed
-
Apr 2022 — Apr 2023 [monthly]
Active Not Recruiting PHASE1_PHASE2
▶ Show 28 earlier versions
-
Dec 2021 — Apr 2022 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Oct 2021 — Dec 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
May 2021 — Oct 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Mar 2021 — May 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Feb 2021 — Mar 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
May 2020 — Nov 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Aug 2019 — May 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jul 2019 — Aug 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jun 2019 — Jul 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Mar 2019 — Jun 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
Status: Recruiting → Active Not Recruiting
-
Feb 2019 — Mar 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2019 — Feb 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Dec 2018 — Jan 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Nov 2018 — Dec 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Oct 2018 — Nov 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Sep 2018 — Oct 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Aug 2018 — Sep 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Jul 2018 — Aug 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE1_PHASE2
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
Phase: PHASE1 → PHASE1_PHASE2
-
Mar 2018 — May 2018 [monthly]
Recruiting PHASE1
-
Nov 2017 — Mar 2018 [monthly]
Recruiting PHASE1
-
Aug 2017 — Nov 2017 [monthly]
Recruiting PHASE1
-
Mar 2017 — Aug 2017 [monthly]
Recruiting PHASE1
-
Feb 2017 — Mar 2017 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Immunocore Ltd
For direct contact, visit the study record on ClinicalTrials.gov .